- Title
- Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay
- Creator
- Diallo, Bakary N
- Creator
- Swart, Tarryn
- Creator
- Hoppe, Heinrich C
- Creator
- Tastan Bishop, Özlem
- Creator
- Lobb, Kevin A
- Date Issued
- 2021
- Date
- 2021
- Type
- text
- Type
- article
- Identifier
- http://hdl.handle.net/10962/177531
- Identifier
- vital:42830
- Identifier
- https://doi.org/10.1038/s41598-020-80722-2
- Description
- Malaria elimination can benefit from time and cost-efficient approaches for antimalarials such as drug repurposing. In this work, 796 DrugBank compounds were screened against 36 Plasmodium falciparum targets using QuickVina-W. Hits were selected after rescoring using GRaph Interaction Matching (GRIM) and ligand efficiency metrics: surface efficiency index (SEI), binding efficiency index (BEI) and lipophilic efficiency (LipE). They were further evaluated in Molecular dynamics (MD). Twenty-five protein–ligand complexes were finally retained from the 28,656 (36×796) dockings.
- Format
- 16 pages
- Format
- Language
- English
- Relation
- Scientific reports
- Relation
- Diallo, B.N.T., Swart, T., Hoppe, H.C., Bishop, Ö.T. and Lobb, K., 2021. Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay. Scientific reports, 11(1), pp.1-15
- Relation
- Scientific reports volume 11 number 1 1 15 2021 2045-2322
- Rights
- Publisher
- Rights
- Use of this resource is governed by the terms and conditions of the Nature Terms and Conditions Statement (https://www.nature.com/info/terms-and-conditions)
- Hits: 1593
- Visitors: 1764
- Downloads: 199
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | SOURCE1 | Potential repurposing of four FDA.pdf | 4 MB | Adobe Acrobat PDF | View Details Download |